Existing cancer drug may protect the heart during certain chemotherapy treatments

The chemotherapy cause doxorubicin is utilized successfully to dainty a scope of cancers but can, arsenic a broadside effect, harm the bosom muscle. Researchers astatine the Heidelberg Faculty of Medicine astatine Heidelberg University person present identified the molecular signaling pathway done which doxorubicin causes cardiac injury. They besides discovered that SAHA (suberoylanilide hydroxamic acid), a cause already approved for the attraction of definite cancers, attenuated harmful mechanisms successful bosom musculus cells successful cell-based and carnal studies and could truthful assistance support the heart.